Astra Not?

“Many scientists have argued that even the loss of a few days in vaccinating vulnerable people could be far costlier than the impact of any rare phenomenon.” Europe is contending with a slow vaccine rollout and an increase in more lethal variants. The suspension of Astra Zeneca’s vaccine is coming at a bad time and might not be warranted. EU regulator ‘convinced’ AstraZeneca benefit outweighs risk. (The warning to Americans here is crystal clear. But we’ve distorted those messages in the past.)